(Q7160547)

Statements

instance of

type of chemical entity

0 references

subclass of

asparaginase

1 reference

stated in

NDF-RT

NDF-RT ID

N0000148371

retrieved

27 February 2018

PEGylated protein

0 references

has use

medication

1 reference

title

Pegaspargase (English)

stated in

DrugBank

language of work or name

English

publication date

17 November 2015

DrugBank ID

00059

image of molecular model or crystal lattice model

Pegaspargasa.png
900 × 900; 750 KB

depicts

ribbon diagram

0 references

active ingredient in

Oncaspar

1 reference

European Medicines Agency product number

EMEA/H/C/003789

reference URL

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003789/human_med_001949.jsp

retrieved

22 March 2017

World Health Organisation international non-proprietary name

pegaspargase (English)

1 reference

stated in

ChEMBL

ChEMBL ID

CHEMBL2108546

language of work or name

English

title

Pegaspargase (English)

retrieved

19 January 2016

medical condition treated

lymphosarcoma

1 reference

stated in

NDF-RT

NDF-RT ID

N0000148371

language of work or name

English

retrieved

13 December 2016

lymphoid leukemia

1 reference

stated in

NDF-RT

NDF-RT ID

N0000148371

language of work or name

English

retrieved

13 December 2016

chronic lymphocytic leukemia

1 reference

stated in

NDF-RT

NDF-RT ID

N0000148371

language of work or name

English

retrieved

13 December 2016

pregnancy category

US pregnancy category C

1 reference

imported from Wikimedia project

English Wikipedia

has characteristic

biopharmaceutical

1 reference

title

Pegaspargase (English)

stated in

DrugBank

language of work or name

English

publication date

17 November 2015

DrugBank ID

00059

subject has role

antineoplastic

1 reference

stated in

Medical Subject Headings

MeSH descriptor ID

C042705

retrieved

15 March 2018

Identifiers